(Q38685909)

5 September 2017

title

Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas (English)

1 reference

5 September 2017

0 references

Hans G Drexler

1 reference

5 September 2017

Sonja Eberth

1 reference

5 September 2017

Stefan Nagel

series ordinal

1 reference

5 September 2017

Roderick A F MacLeod

series ordinal

1 reference

5 September 2017

publication date

4 January 2016

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

page(s)

1015-1020

1 reference

describes a project that uses

5 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Double-hit lymphomas: current paradigms and novel treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Double-hit B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Effect of mutation order on myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Human leukemia and lymphoma cell lines as models and resources

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

A new B-cell line showing a complex translocation (8;14;18) and BCL2 rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Establishment and characterization of acute B-cell lymphocytic leukemia cell line showing (8;14) and (14;18) chromosome translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IGH sequences in complex translocations involving band 3q27.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

A human lymphoma cell line with multiple immunoglobulin rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Establishment and characterization of three new malignant lymphoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Inactivation of the retinoblastoma susceptibility gene in a human high grade non-Hodgkin's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Histiocytic lymphoma cell lines: immunologic and cytogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

A novel human B‐cell line (U‐2904) bearing t(8;14) and t(14;18) translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Cytogenetic harvesting of commonly used tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2015.1108414

10.3109/10428194.2015.1108414

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference